Featured Research

from universities, journals, and other organizations

Study Citing Antioxidant Vitamin Risks Based On Flawed Methodology, Experts Argue

Date:
March 1, 2007
Source:
Oregon State University
Summary:
A study recently published on possible health risks of antioxidant supplements is based on flawed methodology and ignores the broad totality of evidence that comes to largely opposite conclusions, say experts from the Linus Pauling Institute at Oregon State University.

A study recently published on possible health risks of antioxidant supplements is based on flawed methodology and ignores the broad totality of evidence that comes to largely opposite conclusions, say experts from the Linus Pauling Institute at Oregon State University.

The research, which was published in this week’s edition of the Journal of the American Medical Association, concluded that antioxidant supplements such as vitamins A and E may “significantly increase mortality,” and that there was no evidence for any positive effect of vitamin C in the reduction of mortality rates.

However, Balz Frei, professor and director of one of the world’s leading institutes that studies the possible health value of vitamins, phytochemicals and micronutrients, said that the new study’s focus on a selected group of clinical trials disregards the results of other more positive trials, as well as huge amounts of laboratory, animal, and human observational and experimental data.

“This is a flawed analysis of flawed data, and it does little to help us understand the real health effects of antioxidants, whether beneficial or otherwise,” Frei said.

“Instead of causing harm, the totality of the evidence indicates that antioxidants from foods or supplements have many health benefits, including reduced risk for cardiovascular disease, some types of cancer, eye disease and neurodegenerative disease,” he said. “In addition, they are a key to an enhanced immune system and resistance to infection.”

The “meta-analysis” published in JAMA, which is a statistical analysis of previously published data, looked at 815 antioxidant trials but included only 68 of them in its analysis, Frei said. And two of the studies excluded – which were published in the Journal of the National Cancer Institute and the prominent British medical journal Lancet – found substantial benefits and reduced mortality from intake of antioxidant supplements.

“If these two large studies had been included, none of the reported effects on increased mortality would have been significant, with the exception of the effects of beta carotene,” Frei said. “And the research showing a higher incidence of lung cancer in smokers who take supplements of beta carotene or vitamin A is old news, that’s been known for many years. Very high doses of vitamin A are known to have multiple adverse health effects.”

All the new study really demonstrates, Frei said, is a bias toward identifying studies or research that show harm caused by antioxidants, and selective removal of research that shows benefits.

The mean duration of the reviewed trials was 2.7 years, so the implied conclusion is that taking antioxidant supplements can kill people in less than three years, Frei said. It is absurd to think that vitamin supplements could have such an effect, he said, and no biological mechanism has been identified that would explain it. In addition, the causes of death were not considered or were not determined in many of the studies reviewed, and may include accidents or other causes that have nothing to do with diet or oxidative stress.

Most trials cited in the study, Frei said, tested multiple antioxidants and additional interventions in the treatment of disease, including a long list of other dietary supplements and pharmaceutical drugs. The underlying health problems or multiple types of medical, drug and surgical treatments could all interfere with or mask the effects that can be attributed directly to antioxidants, he said.

“These trials don’t tell us anything about the usefulness of antioxidants in the prevention of disease, or whether the supplements had the intended effect of lowering oxidative stress in the body,” Frei said. “It’s like doing a cholesterol-lowering trial without ever measuring serum cholesterol. How can you draw any conclusions from such a poorly-designed study?”

About the Linus Pauling Institute: The Linus Pauling Institute at OSU is a world leader in the study of micronutrients and their role in promoting optimum health or preventing and treating disease. Major areas of research include heart disease, cancer, aging and neurodegenerative disease.


Story Source:

The above story is based on materials provided by Oregon State University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon State University. "Study Citing Antioxidant Vitamin Risks Based On Flawed Methodology, Experts Argue." ScienceDaily. ScienceDaily, 1 March 2007. <www.sciencedaily.com/releases/2007/02/070228172604.htm>.
Oregon State University. (2007, March 1). Study Citing Antioxidant Vitamin Risks Based On Flawed Methodology, Experts Argue. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/02/070228172604.htm
Oregon State University. "Study Citing Antioxidant Vitamin Risks Based On Flawed Methodology, Experts Argue." ScienceDaily. www.sciencedaily.com/releases/2007/02/070228172604.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins